Inventor
MANN SAMUEL EDWARD
GB13 patents
Patents
13 patentsUS9643964B2May 9, 2017
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV9 citations83
US11236084B2Feb 1, 2022
Substituted azaindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021
Cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021
Substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021
Heteroaromatic derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10822342B2Nov 3, 2020
Pyrazolopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10221180B2Mar 5, 2019
Pyrazolopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US10005776B2Jun 26, 2018
Compounds as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US10005773B2Jun 26, 2018
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations40
US10323045B2Jun 18, 2019
Thienopyrimidine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US9981963B2May 29, 2018
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations39
US9981962B2May 29, 2018
Pyrazole derivatives as NIK inhibitors
JANSSEN PHARMACEUTICA NV0 citations38